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Skin is the protective organ of the body with an area around 2 m2. The hazardous
potential of toxins, pathogens and UV radiation are avoided by the protection that skin
supplies (1). UV radiation is the main source of energy that initiates reactive oxygen
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Coenzyme Q10 (Q10) loaded solid lipid nanoparticles
(SLN) were prepared by the high speed homogenization
method and incorporated into Carbopol 974P hydrogels.
Compritol 888 ATO (C888) was employed as the lipid
base; Poloxamer 188 (P188) and Tween 80 (Tw80) were
used as surfactant and co-surfactant. Optimum particle
size with narrow distribution was obtained as 152.2 nm
for blank and 142.4 nm for Q10 loaded SLNs. The overall
charge of loaded SLNs was –13.7 ± 1.3 mV. Q10 entrap-
ment efficiency was 89 % and the production yield was
94 %. Transmission electron microscopy analysis provi-
ded evidence of colloidal size, spherical shape while dif-
ferential scanning calorimetry analysis confirmed recry-
stallization of the lipid after the preparation of SLNs.
Trolox equivalent antioxidant capacity (TEAC) analysis
has shown that antioxidant potential of Q10 can be pro-
tected in SLNs. Rheological characteristics demonstrated
that the SLN incorporating gels were shear thinning and
the mechanical strength of the gels was suitable for topi-
cal application. Diffusion studies from rat abdominal
skin revealed that the delivery of Q10 was doubled in
SLN incorporating gels, approximately 40 µg cm–2, in
comparison with gels prepared with only Q10 (not incor-
porated in SLNs). As a result, it can be stated that Q10-
-SLN loaded gels can be successful delivery systems for
carrying Q10 efficiently into the skin without losing its
antioxidant properties.
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species (ROS). Formation of ROS leads to oxidative damage in DNA, proteins and lipids.
The skin has an enzymatic (superoxide dismutase, catalase, and glutathione peroxidase)
and non-enzymatic (antioxidant) protection mechanism against these damages; however,
excess ROS production overcomes this protection and causes several diseases such as can-
cer (2, 3). Hence, effective delivery of an antioxidant into skin in required levels is an im-
portant challenge. There are two main steps limiting the effective delivery antioxidants, oxi-
dation of the active substance and carrying the active substance to the viable epidermis.
Antioxidants are defined as substances that, when present in a low concentration
compared to that of oxidizable substrates, significantly delay or inhibit oxidation of that
substance (4). In general, antioxidants act by the chain breaking reaction, by reducing
the concentration of reactive oxygen species, by scavenging initiating radicals and by
chelating transition metal catalysts (5). Coenzyme Q10 (Q10) is the only lipid soluble
endogenous antioxidant. It supports ATP generation during aerobic cellular respiration
in the electron transport chain in the mitochondria and inhibits cell membrane peroxida-
tion in reduced form (6, 7). However, it is very difficult to prepare a formulation that
helps Q10 delivery to deeper layers of the skin due to the low aqueous solubility of Q10
(log P >10) and due to the barrier function of stratum corneum (8).
In the second half of the nineties there was an increasing interest in investigating
solid lipid nanoparticles (SLNs) for dermal application. SLNs have many advantages,
especially for dermal applications such as occlusion, modulation of drug release and pe-
netration into the skin (9). Since they are made from solid lipids, chemically unstable
lipid soluble compounds that are sensitive to oxidation can be successfully encapsulated
in the SLNs (8, 10). Several molecules were incorporated into lipid nanoparticles, e.g.,
ascorbyl palmitate, resveratrol, retinol and retinyl palmitate, vitamin E and vitamin E
acetate (8, 11–14). It has been shown that systemic uptake of active substances (e.g., iso-
tretinoin) through skins could be avoided and SLN could increase the accumulative
uptake of the active material in the skin (15). SLNs are produced as liquid dispersions
and their incorporation into hydrogels or emulsions helps enhance the retention time in
the applied area and patient compliance (16, 17).
Hydrogels are generally formed from carbomers that have the ability to absorb wa-
ter, get hydrated and swell by neutralization with a base. Carbomers have been mainly
used in liquid or semi-solid pharmaceutical formulations in order to modify their flow
characteristics (17, 18).
The aim of this work was to carry an efficient amount of Q10 to epidermis via SLNs
without being oxidized. This study was therefore designed to prepare Q10 loaded SLNs
and incorporate them into carbomer based hydrogels. The physicochemical characteri-
zation of SLNs, Trolox equivalent antioxidant capacity (TEAC) analysis and rheological
characterization of hydrogels were conducted. Ex vivo diffusion studies were used to de-
termine the accumulated amount of Q10 in rat skin.
EXPERIMENTAL
Materials
Compritol® 888 ATO (Glyceryl behenate) and Labrasol® were obtained from Gatte-
fossée (France). Poloxamer® 188 (Pluronic F68) was donated by BASF (Germany). Tween®
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80 (Polysorbate 80) and Q10 were obtained from Sigma Aldrich (Italy). Carbopol 974P
was donated by Lubrizol (Germany). All HPLC reagents and chloroform were purcha-
sed from Sigma Aldrich (Italy). The other chemicals were obtained from Merck. All fil-
ters were purchased from Sartorius (Germany).
Preparation of SLNs
Q10 loaded SLNs were prepared by the high shear homogenization method (19) us-
ing two different probes, 8G and 10G, at different concentrations of ingredients (Table I).
C888 was employed as the lipid base; Poloxamer 188 (P188) and Tween 80 (Tw 80) were
used as surfactant and co-surfactant, respectively. As reported in our previous study (14),
the lipid phase Compritol 888 ATO (C888) and Q10- were mixed and heated to 85 °C. At
the same time, the aqueous phase consisting of P188 and Tw 80 in 12.5 mL bidistilled
water was heated to the same temperature. The aqueous phase was mixed with the lipid
phase by Ultra-Turrax (IKA-T25, Germany) at 24000 rpm. The pre-emulsion produced
was dispersed in 12.5 mL bidistilled cold water (4 °C) and kept in the freezer (–20 °C) for
10 minutes to help solidification of nanoparticles. Blank SLNs were prepared in a similar
way, without addition of Q10 (Table I).
Measurement of particle size and polydispersity index
The particle size (PS) and polydispersity index (PI) of SLNs were measured by Pho-
ton Correlation Spectroscopy (Malvern Zetasizer-NanoZS, UK) at 25 °C. The formula-
tions were diluted with bidistilled and filtered (0.45 µm) water before the experiment (n
= 6). Each sample was measured in triplicate.
Measurement of zeta potential
The zeta potential (ZP) of SLN dispersions was measured at 25 °C under an electri-
cal field of 40 V cm–1 (Malvern Zetasizer-NanoZS, UK). The measurements were con-
ducted in triplicate.
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Table I. Content of ingredients in the aqueous dispersion of solid nanoparticles
Formulation
Content (%, m/V)
C888 P188 Tw80 Q10
F1-8G 0.4 0.2 0.1 –
F2-8G 0.8 0.4 0.4 –
F3-8G 1.2 0.6 0.3 –
F1-10G 0.4 0.2 0.1 –
F2-10G 0.8 0.4 0.4 –
F3-10G 1.2 0.6 0.3 –
F3-Q10-10G 1.2 0.6 0.3 0.02
Drug entrapment efficiency
One mL of SLN dispersion was placed in a dialysis bag (cut-off 25 kDa). The bags
were centrifuged for 1 h at 14000 rpm in a medium consisting of 5 % Labrasol® (8). The
amount of Q10 in 5 % Labrasol solution was then analyzed by a validated HPLC method
and the quantity of free drug was calculated. The encapsulated amount of Q10 was cal-
culated by subtracting the free amount of Q10 from the total amount in the dispersion.
Each batch was evaluated three times. The following equation was used to calculate the
entrapment efficiency (EE, %), where Wi is the amount of initial drug and Wf is the
amount of free drug.
The HPLC system (Agilent Series 1100, Italy) consisted of a C18 reverse phase col-
umn (ACE 5-C18 250 mm × 4.6 mm). The mobile phase was a mixture of methanol/
n-hexan 65:35 (V/V). The flow rate and UV wavelength were set at 1 mL min–1 and 275
nm, respectively (20).
Determination of production yield
Nanoparticle suspensions were frozen at –80 °C for 24 h. Freeze-drying was per-
formed at a pressure of 7 kPa for 24 h at –45 °C (Christ Alpha 1-2 LD Freeze Dryer). The
ratio of total theoretical amount to lyophilized powder was calculated.
Transmission electron microscopy (TEM) analysis
A transmission electron microscope (CM12 Philips, the Netherlands) was used for
the morphological examination of SLNs. 2 % (w/V) phosphotungistic acid was used to
stain the samples and after staining they were placed on copper grids for viewing.
Differential scanning calorimetry (DSC) analysis
Q10, C888, blank and loaded SLN formulations were analyzed. The samples to be
tested were weighed between 6–8 mg, sealed in aluminum pans (50 µL) and placed in a
differential scanning calorimeter (DSC 8000 Perkin Elmer). DSC analysis was conducted
under nitrogen flow (20 mL min–1) in a temperature range from 30–300 °C with a heat
flow of 20 °C min–1.
TEAC experiments
Antioxidant activity was measured using the 2,2’-azino-bis(3-ethylbenzothiazoline-
-6-sulfonic acid) (ABTS) method (21).
Potassium persulfate (2.45 mol L–1) was mixed with ABTS (7 mol L–1) in order to
produce an ABTS+ radical. This radical was left in a dark room at 30 °C for 2 days to
reach stable absorbance at 734 nm.
One mL of this solution was placed into a cuvette and its absorbance was detected
as AABTS.+. Then Q10 in 5 % Labrasol and SLN formulations were added into the solu-
tion to give the final Q10 concentration of 26 ng µL–1 and measured at 734 nm for 1–6
min after the initial mixing. All measurements were carried out in triplicate. Inhibition
percentages were calculated as follows:
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Inhibition % = (AABTS.+ – A6.min) × 100/AABTS.+
where AABTS.+ is the absorbance of ABTS+ at 734 nm (0.700 ± 0.02) and A6.min is the
6-min absorbance after the addition of the sample to the ABTS+.
The standard curve of Trolox was obtained using a Trolox standard solution at vari-
ous concentrations (2.5–15 mmol L–1) in a buffer. Absorbance of the sample was com-
pared to that of the standard curve and the antioxidant property was expressed as mol
L–1 Trolox equivalent/mg.
Preparation of gels
Small portions of Carbopol 974P (0.5 %, m/m) were added into a SLN solution under
continuous stirring (1500 rpm) at room temperature for 3–5 h. After 24 hours, the gels
were neutralized with sodium hydroxide (c = 2 mol L–1) to give a gel matrix with a pH
value of 5.4. The prepared gels were centrifuged at 3000 rpm for 15 min to avoid bubbles
and kept in the refrigerator for one night before evaluation. Blank gels were prepared in
the same way without addition of SLNs.
Mechanical properties of gels
Textural profile analysis (TPA) was performed using a software-controlled penetro-
meter (TA-TX Plus, Stable Micro Systems, Godalming, UK) equipped with a 500 g load
cell in the texture profile analysis mode (17, 18). An analytical probe was compressed
twice into the formulations in glass vials to a defined depth (1.5 mm) and at a defined
rate (8 mm s–1), allowing a delay period (15 s) between the end of the first and beginning
of the second compression. Mechanical parameters (hardness, compressibility, adhesive-
ness, cohesiveness, and elasticity) were derived from the resultant force-time curve.
Each experiment was conducted on six different samples.
Rheological studies
All formulations were characterized rheologically using a Haake Mars rheometer
(Thermo Fisher, Karlsruhe, Germany). Continuous shear analysis of formulations was
performed at 25 and 37 °C (± 0.1), in the flow mode, and in conjunction with cone-plate
geometry (diameter 35 mm) with a gap of 0.105 mm. Formulations were placed on the
lower plate and allowed to equilibrate for at least 1 minute prior to analysis.
Oscillatory analysis of each formulation was performed at 25 °C after determination
of its linear viscoelastic region, where the stress was directly proportional to the strain
and the storage modulus remained constant. Frequency sweep analysis was performed
over the frequency range of 0.1–10.0 Hz following application of constant stress at 2 Pa.
Storage modulus (G’), loss modulus (G’’) and dynamic viscosity (h) were determined. In
each case, the dynamic rheological properties of at least six replicates were examined.
Ex vivo diffusion studies
Male, 200–300 g weighing Wistar-albino rat’s abdominal skin was excised immedi-
ately after the animal was sacrificed, and purified from the surrounding tissue. The skin
was placed in a Franz diffusion cell and 600 µL of the formulations (Q10 solution in 5 %
521
E. Korkmaz et al.: Development and evaluation of coenzyme Q10 loaded solid lipid nanoparticle hydrogel for enhanced dermal deli-
very, Acta Pharm. 63 (2013) 517–529.
Labrasol, Q10 gel, Q10-SLN and Q10 loaded SLN gel) were evaluated. The receptor
phase consisted of 5 % Labrasol solution at 37 °C and sink conditions were taken into
consideration. The formulations to be tested were kept in contact with the tissue for 24 h
and, at certain time intervals, the Q10 amount was determined in 300 µL samples taken
from the receptor phase. After 24 h, skin samples were taken, the excess formulation was
removed, and skin surface was cleaned with dry paper. Tissue samples were cut into
small pieces and Q10 accumulated in the skin was extracted with the aid of a horizontal
shaker in 2 mL of methanol/n-hexan (65:35) for 24 h.
Statistical analysis
Statistical analysis was conducted by ANOVA followed by Tukey’s test for compari-
sons between groups. 0.05 was taken as the p value, to indicate statistical significance (p
< 0.05).
RESULTS AND DISCUSSION
Physical properties of nano-systems might affect the in vivo behavior. In our previ-
ous study, it was reported that particle size and zeta potential have important roles in
the dermal penetration properties of lipid nanoparticles (10). The data in terms of PS
and PI of SLNs are given in Table II. As can be seen from Table II, an increment in the
lipid base concentration caused an increment in particle size. The effect of C888 concen-
tration on the PS values was more obvious with probe 8G. The variability of PS was en-
hanced with probe 8G. Therefore the formulations prepared with Probe 10G were more
uniform and the inter-formulation variability was lower.
Increment of lipids in the system increased the PS detected. PI is a very important
parameter to understand the uniformity of the particle size dimension; values below 0.5
indicate the uniformity of the system. If the system is not uniform, aggregation may oc-
cur. The PI was small enough to state that the formulations prepared with the bigger
probe 10 G were homogenous in terms of dimension. Nano-sized particles have some
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Table II. The particle size and polydispersity index of formulationsa
Formulation PS (nm) PI
F1-8G 232.95 ± 27.90 0.502 ± 0.07
F2-8G 268.00 ± 17.94 0.402 ± 0.01
F3-8G 336.40 ± 82.71 0.405 ± 0.04
F1-10G 137.40 ± 21.40 0.364 ± 0.03
F2-10G 152.20 ± 14.04 0.351 ± 0.04
F3-10G 164.10 ± 9.35 0.294 ± 0.05
F3-Q10-10G 142.40 ± 17.90 0.272 ± 0.03
a Mean ± SD
advantages in overcoming the stratum corneum barrier and penetrating into deeper lay-
ers of the skin. Nano-size can act in favor of the interaction of solid lipids of the formula-
tion with lipids of the stratum corneum and passing through the pores in the skin (10,
19). The smallest and homogenous dispersion was obtained with F3. The production
yield was 94 ± 1 %.
Addition of Q10 into the lipid of F3 helped to form smaller particles. This behavior
could be attributed to the polymorphism of Q10 and the lipid. Since Q10 is a highly lipo-
philic substance, it is likely that Q10 was solubilized in C888, which might affect the re-
crystallization process or the activity of surfactants.
DSC analysis was performed to evaluate the crystallization. It can be seen from Fig.
1 that the peak of Q10 at 54 °C disappeared indicating the solubility in the lipid phase
and that there was a slight change in the melting point peak of C888 in SLNs (from 77 to
74 °C). This change might be responsible for the smaller particle size detected. As the
lipid melted earlier, a homogenous pre-emulsion could be formed with smaller droplets.
In a previous study, Q10 was found to be dissolved in the lipid matrix (cetyl palmitate),
similarly to the results of our study. After cooling, the absence of the melting peak of
Q10 was attributed to the formation of a super-cooled melted state, amorphous or mo-
lecular dispersed state of Q10 in the mixture (15). It was seen in another study that the
height of the endotherm in the thermogram of SLN containing Q10 was less than that in
SLN without Q10, suggesting loss of crystallinity of the lipids and Q10 after incorpora-
tion into SLN (11).
Q10 addition reduced the overall charge of the SLNs from –(18.6 ± 1.2) to –(13.7 ±
1.3) mV, as it was also seen in our previous studies conducted with cyclosporine A (22).
The drug entrapment efficiency of Q10 was determined as 89 % by a validated HPLC
method. This high encapsulation amount was expected due to very high lipophilicity of
Q10 (log P > 10).
Colloid dimension and spherical shape of SLNs are supported by TEM images (Fig. 2).
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Fig. 1. Thermograms of: a) Q10, b) C888, c) blank and d) Q10 loaded SLNs obtained with DSC.
It is known that the structure of SLNs protects labile drugs from degradation or oxi-
dation by encapsulation (8–11, 17). TEAC experiments showed that the encapsulation in
SLNs was successful in protecting Q10 from oxidation. Q10 in 5 % Labrasol solution and
Q10 loaded SLNs displayed TEAC around 11 and 0.28 mM/L, respectively. This result
indicated that ABTS radical was not able to interact with Q10 whilst it was protected by
a lipid matrix.
Q10 loaded SLNs were successfully prepared but their application onto the skin to
deliver the required amount of Q10 into deeper layers was very important. SLN incor-
porating gels were formed to increase the retention time on the applied area. Three dif-
ferent formulations were prepared; blank gels, Q10 incorporating gels and Q10 loaded
SLN incorporating gels. Texture profile analysis was conducted to understand the me-
chanical properties of the gels. As can be seen from Table III, the addition of SLNs did
not change the mechanical properties of gels (p > 0.05 for all parameters).
It is known that the parameters such as hardness, compressibility, adhesiveness, co-
hesiveness affect the performance of topical semisolid formulations, e.g., ease of removal
from the container, ease of application to the surface and retention of the product at the
site of application. Compressibility is the force required to deform the samples during
compression. Hardness and compressibility describe the stress/work required to remo-
ve the sample from the container and to subsequently spread over the site of applica-
tion. These characteristics quantify sample deformation under compression. Gel hard-
ness and compressibility should be low to allow the gel to be easily removed from the
container and spread onto the bio-surface (23, 24).
It was reported in a study of Jones et al. that sodium carboxymethylcellulose at a
concentration of 6 % had compressibility of 1.87 ± 0.34 N mm (24). Similarly, in a study
of Bonacucina et al., 1.240 ± 0.46 N mm was reported to be suitable for topical admini-
stration. (25). Our results are in accord with these previous studies.
In this study, elastic modulus (G’), viscous modulus (G’’) and viscosity were moni-
tored to define the gel structure. The elastic (or storage) modulus represents elastic stor-
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Fig. 2. TEM image of Q10 loaded SLN.
age of energy and it is a measure of a well-structured material. The viscous (or loss) mo-
dulus represents loss of viscous energy and it will be large when the sample is viscous
(26). In the presence of a gel structure, G’ and G’’ are frequency independent whilst for
concentrated solutions there is a frequency dependence of G’ and G’’ (27). A definition
of Burchard and Ross-Murphy (28) is that a gel shows a plateau in the real part of the
complex modulus extending over an appreciable window of frequencies. Briefly, G’ mo-
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Blank gel 0.178 ± 0.008 1.121 ± 0.101 0.833 ± 0.073 0.976 ± 0.836 0.595 ± 0.040
Q10-Gel 0.191 ± 0.002 1.155 ± 0.663 0.757 ± 0.581 0.973 ± 0.001 0.540 ± 0.325
Q10SLN-Gel 0.195 ± 0.005 1.479 ± 0.323 1.080 ± 0.268 0.967 ± 0.026 0.706 ± 0.087
a Mean ± SD.
Fig. 3. Oscillation graphics of: a) blank gel, b) Q10 gel and c) Q10 loaded SLN incorporating gel at 25 °C.
dulus had to be greater than G’’ modulus in the entire frequency range examined and
both moduli had to be frequency independent.
As can be seen from Fig. 3, the oscillation graphics indicated that the formulations
prepared were of gel characters since G’ was greater than G’’. Incorporation of SLNs into
gels did not affect gel behavior.
Viscosity profiles (Fig. 4) showed that the gels started flowing when shear stress
was increased. This kind of behavior indicated a shear-thinning system for all formula-
tions. Similarly, in a previous study Carbopol hydrogels incorporating liposomes and
cyclodextrin have shown shear-thinning behavior (29).
Farboud et al. (11) evaluated the release of Q10 loaded SLN oil/water creams
through cellulose nitrate membranes. It was reported in their study that the percentage
of released Q10 from simple cream was higher than for SLN and SLN cream in the first
hour, but after 7 h SLN and SLN cream released almost all of the Q10 content whereas
simple cream released only 40 %. However, in our study in which rat abdominal skin
was used, there was no diffusion of Q10 through the receptor phase during 24 h of ob-
servation. Therefore the amount of Q10 accumulated in the skin could be determined.
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Fig. 4. Viscosity vs. shear rate profiles of: a) blank gel, b) Q10 gel and c) Q10 loaded SLN incorporat-
ing gel at room and body temperature.
As can be seen from Fig. 5, the penetration of Q10 into the skin was increased by its
encapsulation in the SLN formulation. The small size and lipophilicity of the particles
helped the delivery of Q10 into the skin. The delivery of Q10 was almost doubled in
SLN and SLN incorporating gels compared to the gel formulation prepared with solely
Q10 (not incorporated in SLNs). It is known that small size ensures close contact with
the stratum corneum and can increase the amount of drug absorbed by the skin (12).
Zhaou et al. (30) reported that Q10 loaded lipid nanocapsules accumulated in both epi-
dermis and dermis. Since oxidative stress affects several pathways, the delivery of Q10
into the skin is particularly important (31). The gel without SLNs also acted in favor of
Q10 penetration. It was supposed that as the residence time of Q10 was prolonged, the
penetration of Q10 could be elevated.
CONCLUSIONS
Q10 loaded SLNs could be successfully prepared by the high speed homogenization
method with high drug loading and production yield. The antioxidant activity of Q10
could be protected from environmental conditions in the SLN matrix. SLN incorporation
into hydrogels did not make dramatic changes in the gel’s mechanical and rheological
characteristics. The formulation obtained was suitable for topical, especially dermal, ap-
plications. Even the prolongation of Q10 presence in the application area increased its
skin penetration. In addition, the nano-size obtained by a lipid matrix of SLN helped to
establish closer contact with stratum corneum and increased the amount of Q10 ab-
sorbed by the skin in comparison with other formulations. As a result, it could be con-
cluded that Q10-SLN incorporating gels can be regarded successful delivery systems for
delivering Q10 efficiently into the skin without losing its antioxidant properties.
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Fig. 5. The amount of Q10 determi-
ned from the rat abdominal skin
tissue.
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